6 completed, 1 no longer available. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow DEKK-TEC, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DM-CHOC-PEN for Brain Tumors in AYA Subjects DM-CHOC-PEN - Advanced Cancer, Brain Metastases | Phase 2 | Completed | DEKK-TEC, Inc. | 20 | 2019-01-01 | 2022-11-08 |
| DM-CHOC-PEN Plus Radiation for Brain Tumors 4-Demethyl-4-cholesteryloxycarbonylpenclomedine - Advanced Cancer | Phase 1 | Completed | DEKK-TEC, Inc. | 19 | 2016-02-05 | 2022-11-04 |
| Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors 4-Demethyl-4-cholestryloxycarbonylpenclomedine - Primary Brain Tumors, Metastatic Malignant Neoplasm to Brain | Phase 2 | Completed | DEKK-TEC, Inc. | 29 | 2013-09-01 | 2020-09-16 |
| Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer" DM-CHOC-PEN - Advanced Cancer | Phase 1 | Completed | DEKK-TEC, Inc. | 23 | 2010-09-01 | 2020-08-04 |
| Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer DM-CHOC-PEN - Advanced Cancer, Brain Involvement | Phase 1 | Completed | DEKK-TEC, Inc. | 22 | 2010-09-01 | 2020-08-04 |
| Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders A-007 - Sarcoma, Kaposi, HIV Infections | Phase 1 | Completed | DEKK-TEC, Inc. | 25 | 2005-06-24 | |
| A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers 4-Demethyl-4-cholesteryloxycarbonylpenclomedine - Advanced Cancer | No longer available | DEKK-TEC, Inc. | 2020-08-18 |
Brain Neoplasms (4) · Glioblastoma (2) · Acquired Immunodeficiency Syndrome (1) · Breast Neoplasms (1) · HIV Infections (1) · Lung Neoplasms (1) · Lymphoproliferative Disorders (1) · Melanoma (1) · Neoplasms (1) · Sarcoma, Kaposi (1) · Skin Neoplasms (1)
4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (1)
United States (7)
Marcus L Ware, MD (3) · Ali Baghian, MD (1) · Lee R Morgan, MD, PhD (1) · Lee Roy Morgan, MD, PhD (1) · Steven DiBiase, MD (1) · Tallat Mahmmod, MD (1)
R43CA132257 (2), R44CA125871 (1)